Peripheral Diamondback 1.50 Solid OAD, a percutaneous orbital atherectomy system indicated for use as therapy in patients with occlusive atherosclerotic disease in peripheral arteries and who are acceptable candidates for percutaneous transluminal atherectomy.
Cardiovascular Systems, Inc. (CSI) is removing the products because it was identified that the labeling for two lots of product s were potentially inadvertently switched during production.
FL, IL, MI, MN, MO, NY, SC, TX, and WI
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-0506-2018